CN1210737A - Medicine for curing early and medium leukemia - Google Patents
Medicine for curing early and medium leukemia Download PDFInfo
- Publication number
- CN1210737A CN1210737A CN 98119784 CN98119784A CN1210737A CN 1210737 A CN1210737 A CN 1210737A CN 98119784 CN98119784 CN 98119784 CN 98119784 A CN98119784 A CN 98119784A CN 1210737 A CN1210737 A CN 1210737A
- Authority
- CN
- China
- Prior art keywords
- medicine
- leukemia
- medium
- early
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
By utilizing family handed specific prescription and combining modern Chinese and Western medical principle, the present invention prepares the medicine for curing acute and chonic leukemia. The medicine uses low cost and easy-to-obtain material and has high cure rate on early and medium leukemia and no toxic side effect.
Description
The present invention relates to the leukemic medicine of a kind of specialty treatment early and middle portion.
Leukemia is a kind of leukemia or the super cancer that modern medicine is thought, suffering from leukemia person at present all is to fail to respond to any medical treatment or relief of symptoms, it is reported that the leukemic method of treatment has following three kinds: 1. regularly exchange blood transfusion to the patient; 2. medicine supporting treatment; 3. regular immunotherapy, but these therapies are all cured the symptoms, not the disease.One cause huge financial burden to the patient; The two can not be cured, and can only briefly delay patient's life, and its result keeps away unavoidably and devitalized by this fearful serious illness of leukemia.
Purpose of the present invention provides a kind of elimination early metaphase leukemic medicine, and it comprises can treat acute and chronic leukemia.
The object of the present invention is achieved like this, below is the prescription of this medicine: Hypodematium crenatum (Forsk.) Kuhn bone meal 90%, testis Mus powder 3%, Crinis Carbonisatus 4%, true bovine calculus powder 3% gold medal juice (clothes earlier) take with yellow wine
Owing to take the such scheme pharmaceutical formulation, can the leukemic patient of the person's of making early metaphase give the thoroughly treatment of elimination, show that from present 24 routine patients cure rate can reach more than 90%, and curative effect of the present invention is short, it is without any side effects during the patient takes, can treat acute and chronic leukemia completely, especially it is all good (because if the leukaemic is to the later stage to treat early metaphase leukemia effect, essentially no any resistivity or to the absorbability of this medicine in patient's body, therefore, all invalid to any Drug therapy).This Drug therapy cost is compared cost with change-blood, immunotherapy and is significantly less than the former, has alleviated very big financial burden to the patient.The leukemic patient who makes medical circle be referred to as incurable disease obtains life for the second time.
Claims (1)
1, a kind of leukemic medicine of prometaphase of specially controlling, it comprises Hypodematium crenatum (Forsk.) Kuhn bone meal, testis Mus powder, Crinis Carbonisatus, true bovine calculus powder, golden juice, takes with yellow wine, it is characterized in that containing in this medicine the male mouse testis of drying up the back pulverizing.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 98119784 CN1210737A (en) | 1998-09-22 | 1998-09-22 | Medicine for curing early and medium leukemia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 98119784 CN1210737A (en) | 1998-09-22 | 1998-09-22 | Medicine for curing early and medium leukemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1210737A true CN1210737A (en) | 1999-03-17 |
Family
ID=5226463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 98119784 Pending CN1210737A (en) | 1998-09-22 | 1998-09-22 | Medicine for curing early and medium leukemia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1210737A (en) |
-
1998
- 1998-09-22 CN CN 98119784 patent/CN1210737A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU766216B2 (en) | Method for the treatment of cerebral ischaemia and use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischaemia | |
| RU2162327C2 (en) | Treatment of cancer patient and prophylaxis of metastasis | |
| NO20014842L (en) | Docet shaft in combination with rhuMAb HER2 for the treatment of cancer | |
| WO2004017913A3 (en) | Arginine silicate inositol complex and use thereof | |
| Di Filippo et al. | The role of hyperthermic perfusion as a first step in the treatment of soft tissue sarcoma of the extremities | |
| HK1055080A1 (en) | Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders | |
| MY105798A (en) | Treatment of leukocyte dysfunction with gm-csf. | |
| HUP0003256A2 (en) | Use of pentosan polysulfate for preparing medicament useful in treating chronic progressive vascular scarring diseases | |
| CN1210737A (en) | Medicine for curing early and medium leukemia | |
| LT2006024A (en) | Tetrapeptide regulating blood glucose level in diabetes mellitus | |
| CA2516458A1 (en) | Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis | |
| WO2001080895A3 (en) | Methods and compositions for the treatment of cardiac indications | |
| CN102614365B (en) | Traditional Chinese medical composition for treatment of breast tumor | |
| Shannon | Jin Shin Jyutsu outcomes in a patient with multiple myeloma | |
| Prescott | Doxil offers hope to KS sufferers | |
| CN100352477C (en) | Wound healing medicine | |
| CN101161277A (en) | Mammary gland hyperplasia wine | |
| US5081129A (en) | Method of treatment of anemia with seratonin antagonists | |
| CN1164291C (en) | Chinese proprietary for treating protrusion of lumber interverterbral disc and its prepn. | |
| Saleem et al. | Hypophosphatemia induced encephalopathy after intravenous iron carboxymaltase administration-A rare and important complication. | |
| RU2142794C1 (en) | Medicinal remedy and method for treating organism with medicinal substances | |
| US90962A (en) | Improved medical compound | |
| Burton | Proton-Beam RT Effective Against Choroidal Melanoma | |
| CN100402076C (en) | Medicine for treating gastropathy and its preparation method | |
| JP2010265249A (en) | Method for prevention and treatment of refractory disease such as cancer and rejuvenating and antiaging method by instillation of deuterium-decreased water (superlight water, ddwater(r)) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |